Informed Consent in Aesthetic Practice: Insurer Expectations vs Practice Reality

Informed consent means something specific to an insurer assessing a cosmetic claim. It means a documented process: evidence of what was disclosed before treatment, what the patient was told about risks and limitations, what they understood, and what they agreed to. Something that can be produced, examined, and defended. Understanding why that standard is rarely met in cosmetic practice requires understanding the conditions under which most aesthetic consultations actually take place.

Minimally invasive cosmetic practice does not operate like a surgical unit or a GP surgery. Appointments are short, often thirty minutes or less. In a significant portion of the sector, treatment takes place on the same day as the consultation, sometimes within the same appointment. There is no standardised consent framework across the industry, no mandatory waiting period between consultation and treatment for most non-surgical procedures, and no requirement for a structured pre-consultation process of any kind. Practitioners are working within a commercial environment where time is limited, patient expectations are high, and the pressure to proceed is structural rather than exceptional.

Informed consent in aesthetic practice has developed its own meaning. For most aesthetic practitioners, it is a combination of verbal explanation, practitioner judgement that the patient appears to understand, and a signed consent form. That process is not experienced as inadequate. Practitioners generally approach consent from a duty of care perspective: they feel they are on the same page with the patient, they have covered the key points, and the signature confirms agreement. The legal question — how would this process look if it were examined in a dispute — is rarely the frame through which consent is considered at the point of treatment.

The signed consent form is where most practitioners believe their protection resides, and it is a weaker document than most of them appreciate. A signature confirms a form was presented. It does not confirm that its contents were explained clearly, understood meaningfully, or that the patient's expectations and motivations were ever discussed. In a dispute where the patient's account of what they were told conflicts with the practitioner's, the form does not resolve that conflict. It establishes presence, not understanding, and the rest becomes a reconstruction of a conversation with no independent record.

The Biggest Gap in Informed Consent in Aesthetic Practice

The reconstruction problem is sharpest in the areas cosmetic consent processes are least likely to cover at all. Standard forms address physical risks — scarring, asymmetry, infection, bruising. What is almost never documented is any discussion of psychological risks, patient expectations, or the emotional outcomes a patient was hoping the procedure would deliver. Those conversations may occur. Many practitioners would say they do. But without a structured, documented process for having them, there is no evidence they took place, and in a dispute, that absence is significant. A practitioner's recollection of a conversation they cannot evidence is a fragile basis for defending a claim built around expectation, dissatisfaction, or alleged psychological unsuitability.

For insurers, the practical implication is that "informed consent was obtained" and "a defensible consent process was followed" are not the same statement in cosmetic practice, and the gap between them is routinely where contested claims take shape. The signed form that most practitioners treat as their record of consent is, in many cases, the beginning and end of a process that was never designed to withstand scrutiny.